Cyberonics Seeking Federal Support For NCP Depression Pivotal Trial
This article was originally published in The Gray Sheet
Executive Summary
Cyberonics' NCP NeuroCybernetic Prosthesis system eliminated symptoms of major depressive episodes in at least 25% of patients having completed the acute phase of a pilot study evaluating the vagus nerve stimulation therapy for major chronic depression.